Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Shevchenko, Evgeny K ^a   Makarevich, Pavel I ^a,b   Tsokolaeva, Zoya I ^a   Boldyreva, Maria A ^a   Sysoeva, Veronika Yu ^b   Tkachuk, Vsevolod A ^a,b   Parfyonova, Yelena V ^a,b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Adeno associated virus; Adipose stromal cells; Cell therapy; Gene modified cells; Ischemia; Therapeutic angiogenesis; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SCATTER FACTOR; UROKINASE; VASCULOTROPIN 165;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC GENE THERAPY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PROTEIN SECRETION; REVASCULARIZATION; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADIPOSE TISSUE; ADULT; ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELL TRANSPLANTATION; COLLAGEN; CULTURE MEDIA, CONDITIONED; DEPENDOVIRUS; DRUG COMBINATIONS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; ISCHEMIA; LAMININ; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878511606     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-138     Document Type: Article

References (58)

1. Eckhouse SR, Jones JA, Spinale FG. Gene targeting in ischemic heart disease and failure: translational and clinical studies. Biochem Pharmacol 2013, 85:1-11. 10.1016/j.bcp.2012.08.018, 22935384.
2. Beohar N, Rapp J, Pandya S, Losordo DW. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol 2010, 56:1287-1297. 10.1016/j.jacc.2010.05.039, 3123891, 20888519.
3. Deveza L, Choi J, Yang F. Therapeutic angiogenesis for treating cardiovascular diseases. Theranostics 2012, 2:801-814. 10.7150/thno.4419, 3425124, 22916079.
4. Gupta R, Tongers J, Losordo DW. Human studies of angiogenic gene therapy. Circ Res 2009, 105:724-736. 10.1161/CIRCRESAHA.109.200386, 2770893, 19815827.
5. Ishikawa K, Tilemann L, Fish K, Hajjar RJ. Gene delivery methods in cardiac gene therapy. J Gene Med 2011, 13:566-572. 10.1002/jgm.1609, 21954037.
6. Shimamura M, Morishita R. Naked plasmid DNA for gene therapy. Curr Gene Ther 2011, 11:433. 10.2174/156652311798192824, 22023468.
7. Reffelmann T, Kloner RA. Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med 2009, 4:709-719. 10.2217/rme.09.42, 19761396.
8. Menasche P. Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure. J Cardiovasc Transl Res 2008, 1:201-206. 10.1007/s12265-008-9017-1, 20559920.
9. Germani A, Di Campli C, Pompilio G, Biglioli P, Capogrossi MC. Regenerative therapy in peripheral artery disease. Cardiovasc Ther 2009, 27:289-304. 10.1111/j.1755-5922.2009.00105.x, 19903190.
10. El-Ftesi S, Chang EI, Longaker MT, Gurtner GC. Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plast Reconstr Surg 2009, 123:475-485. 10.1097/PRS.0b013e3181954d08, 2878769, 19182604.
11. Madonna R, Renna FV, Cellini C, Cotellese R, Picardi N, Francomano F, Innocenti P, De Caterina R. Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. Eur J Clin Invest 2011, 41:126-133. 10.1111/j.1365-2362.2010.02384.x, 20874854.
12. Sun Y, Li W, Lu Z, Chen R, Ling J, Ran Q, Jilka RL, Chen XD. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2011, 25:1474-1485.
13. Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, Spagnoli A. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther 2010, 10:1663-1679. 10.1517/14712598.2010.531257, 3057936, 21058931.
14. Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010, 21:1513-1526. 10.1089/hum.2010.165, 2978545, 20825283.
15. Lavoie JR, Stewart DJ. Genetically modified endothelial progenitor cells in the therapy of cardiovascular disease and pulmonary hypertension. Curr Vasc Pharmacol 2012, 10:289-299. 10.2174/157016112799959413, 22239631.
16. Liu XH, Bai CG, Xu ZY, Huang SD, Yuan Y, Gong DJ, Zhang JR. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc Res 2008, 76:23-30. 10.1016/j.mvr.2008.02.005, 18462761.
17. Sen S, Merchan J, Dean J, Ii M, Gavin M, Silver M, Tkebuchava T, Yoon YS, Rasko JE, Aikawa R. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther 2010, 21:1327-1334. 10.1089/hum.2010.006, 20497036.
18. Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 2010, 15:86-91. 10.1097/MOT.0b013e328334f074, 19949335.
19. Merfeld-Clauss S, Gollahalli N, March KL, Traktuev DO. Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation. Tissue Eng Part A 2010, 16:2953-2966. 10.1089/ten.tea.2009.0635, 2928048, 20486792.
20. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008, 102:77-85. 10.1161/CIRCRESAHA.107.159475, 17967785.
21. Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, Murphy M, Johnstone BH, Ingram DA, March KL. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 2009, 104:1410-1420. 10.1161/CIRCRESAHA.108.190926, 19443841.
22. Gray SJ, Samulski RJ. Optimizing gene delivery vectors for the treatment of heart disease. Expert Opin Biol Ther 2008, 8:911-922. 10.1517/14712598.8.7.911, 18549322.
23. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011, 437:169-183. 10.1042/BJ20110301, 21711246.
24. Traktuev DO, Tsokolaeva ZI, Shevelev AA, Talitskiy KA, Stepanova VV, Johnstone BH, Rahmat-Zade TM, Kapustin AN, Tkachuk VA, March KL, Parfyonova YV. Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Molecular therapy: the journal of the American Society of Gene Therapy 2007, 15:1939-1946.
25. Grimm D, Kleinschmidt JA. Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther 1999, 10:2445-2450. 10.1089/10430349950016799, 10543610.
26. Jang HS, Kim HJ, Kim JM, Lee YS, Kim KL, Kim JA, Lee JY, Suh W, Choi JH, Jeon ES, et al. A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle. Molecular therapy: the journal of the American Society of Gene Therapy 2004, 9:464-474.
27. Ball SG, Shuttleworth CA, Kielty CM. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 2007, 177:489-500. 10.1083/jcb.200608093, 2064818, 17470632.
28. Calderon D, Planat-Benard V, Bellamy V, Vanneaux V, Kuhn C, Peyrard S, Larghero J, Desnos M, Casteilla L, Puceat M, et al. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. J Cell Mol Med 2012, 16:1544-1552. 10.1111/j.1582-4934.2011.01435.x, 21895965.
29. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301. 10.1634/stemcells.2005-0342, 16410387.
30. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, Di Halvorsen Y, Storms RW, Goh B, Kilroy G, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385. 10.1634/stemcells.2005-0234, 16322640.
31. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298. 10.1161/01.CIR.0000121425.42966.F1, 14993122.
32. Rubina K, Kalinina N, Efimenko A, Lopatina T, Melikhova V, Tsokolaeva Z, Sysoeva V, Tkachuk V, Parfyonova Y. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 2009, 15:2039-2050. 10.1089/ten.tea.2008.0359, 19368510.
33. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003, 183:355-366. 10.1016/S0014-4886(03)00089-X, 14552877.
34. Kang S, Yang YJ, Li CJ, Gao RL. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 2008, 19:327-335. 10.1097/MCA.0b013e328300dbd3, 18607170.
35. Shi YY, Nacamuli RP, Salim A, Longaker MT. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg 2005, 116:1686-1696. 10.1097/01.prs.0000185606.03222.a9, 16267433.
36. Huang SC, Wu TC, Yu HC, Chen MR, Liu CM, Chiang WS, Lin KM. Mechanical strain modulates age-related changes in the proliferation and differentiation of mouse adipose-derived stromal cells. BMC Cell Biol 2010, 11:18. 10.1186/1471-2121-11-18, 2841110, 20219113.
37. Efimenko A, Starostina E, Kalinina N, Stolzing A. Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med 2011, 9:10. 10.1186/1479-5876-9-10, 3033332, 21244679.
38. Deyle DR, Russell DW. Adeno-associated virus vector integration. Curr Opin Mol Ther 2009, 11:442-447. 2929125, 19649989.
39. Hsu CC, Li HP, Hung YH, Leu YW, Wu WH, Wang FS, Lee KD, Chang PJ, Wu CS, Lu YJ, et al. Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun 2010, 402:228-234. 10.1016/j.bbrc.2010.09.131, 20933502.
40. Stilwell JL, Samulski RJ. Role of viral vectors and virion shells in cellular gene expression. Molecular therapy : the journal of the American Society of Gene Therapy 2004, 9:337-346.
41. Bantel-Schaal U, Stohr M. Influence of adeno-associated virus on adherence and growth properties of normal cells. J Virol 1992, 66:773-779. 240777, 1309911.
42. Casteilla L, Planat-Benard V, Cousin B, Silvestre JS, Laharrague P, Charriere G, Carriere A, Penicaud L. Plasticity of adipose tissue: a promising therapeutic avenue in the treatment of cardiovascular and blood diseases?. Arch Mal Coeur Vaiss 2005, 98:922-926.
43. Prunet-Marcassus B, Cousin B, Caton D, Andre M, Penicaud L, Casteilla L. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 2006, 312:727-736. 10.1016/j.yexcr.2005.11.021, 16386732.
44. Fischer LJ, McIlhenny S, Tulenko T, Golesorkhi N, Zhang P, Larson R, Lombardi J, Shapiro I, DiMuzio PJ. Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res 2009, 152:157-166. 10.1016/j.jss.2008.06.029, 2773556, 19883577.
45. Ahmed S, Yang HK, Ozcam AE, Efimenko K, Weiger MC, Genzer J, Haugh JM. Poly(vinylmethylsiloxane) elastomer networks as functional materials for cell adhesion and migration studies. Biomacromolecules 2011, 12:1265-1271. 10.1021/bm101549y, 21361274.
46. Manso AM, Kang SM, Ross RS. Integrins, focal adhesions, and cardiac fibroblasts. Journal of investigative medicine: the official publication of the American Federation for Clinical Research 2009, 57:856-860.
47. Goessler UR, Bugert P, Bieback K, Stern-Straeter J, Bran G, Hormann K, Riedel F. Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. Int J Mol Med 2008, 21:271-279.
48. Dreher L, Elvers-Hornung S, Brinkmann I, Huck V, Henschler R, Gloe T, Kluter H, Bieback K. Cultivation in human serum reduces adipose tissue-derived mesenchymal stromal cell adhesion to laminin and endothelium and reduces capillary entrapment. Stem Cells Dev 2013, 22:791-803. 10.1089/scd.2012.0051, 23025550.
49. Brindle NP, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 2006, 98:1014-1023. 10.1161/01.RES.0000218275.54089.12, 2270395, 16645151.
50. Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb Haemost 1999, 82:298-304.
51. Bobik A, Tkachuk V. Metalloproteinases and plasminogen activators in vessel remodeling. Curr Hypertens Rep 2003, 5:466-472. 10.1007/s11906-003-0054-5, 14594565.
52. Traktuev DO, March KL, Tkachuk VA, Parfenova EV. [Adipose tissue stromal cells - multipotent cells with therapeutic potential for stimulation of angiogenesis in tissue ischemia]. Kardiologiia 2006, 46:53-63.
53. Nishishita T, Lin PC. Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 2004, 91:584-593. 10.1002/jcb.10718, 14755687.
54. Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB, Wakhloo AK, Webster KA. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther 2005, 12:762-771. 10.1038/sj.gt.3302481, 15772688.
55. Cao Y. Monotherapy versus combination therapy of angiogenic and arteriogenic factors for the treatment of ischemic disorders. Curr Mol Med 2009, 9:967-972. 10.2174/156652409789712747, 19925409.
56. Shyu KG, Chang H, Isner JM. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci 2003, 73:563-579. 10.1016/S0024-3205(03)00318-7, 12770612.
57. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19:1029-1034. 10.1038/nbt1101-1029, 11689847.
58. Makarevich P, Tsokolaeva Z, Shevelev A, Rybalkin I, Shevchenko E, Beloglazova I, Vlasik T, Tkachuk V, Parfyonova Y. Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. PLoS One 2012, 7:e38776. 10.1371/journal.pone.0038776, 3374822, 22719942.